I get all of that.
If I can weigh in on it with this it might prove beneficial.
My view is that our product offering was not up to scratch up until mid 2024 after A2 and Tenns.
I also see it as beneficial that we have fresh blood in the CTO and CDO chairs respectively. A fresh perspective has, in my opinion, become very important and necessary. Not taking anything away from the cofounders but moving on from there has been very important in my opinion. You'll never hear this from the company of course because they won't disparage the founders. I'm not trying to do that either but am just being frank.
I believe that since the product suite has been reinvigorated the company has had numerous conversations with potential customers but have hit the disclosure hurdle several times. See my previous post for further explanation.
I will never defend the miscalculations of success as you point out about 2022, 2023 and 2024 but, and it is a big but, the company needs to deliver in the early part of 2025 in order to move us forward and towards a successful US listing.
there's plenty of work to be done but it is not insurmountable.
They need to start with building on their own credibility and massively improving their delivery of messages to shareholders.
- Forums
- ASX - By Stock
- BRN
- Ann: BrainChip Evaluates Redomiciling to US
BRN
brainchip holdings ltd
Add to My Watchlist
0.00%
!
20.0¢

Ann: BrainChip Evaluates Redomiciling to US, page-194
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
20.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $405.0M |
Open | High | Low | Value | Volume |
20.5¢ | 21.0¢ | 20.0¢ | $1.544M | 7.615M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 61852 | 20.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
20.5¢ | 217258 | 9 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 32537 | 0.200 |
25 | 968327 | 0.195 |
38 | 1574473 | 0.190 |
40 | 1943108 | 0.185 |
65 | 1281316 | 0.180 |
Price($) | Vol. | No. |
---|---|---|
0.205 | 179258 | 6 |
0.210 | 1653584 | 26 |
0.215 | 846002 | 16 |
0.220 | 1267378 | 34 |
0.225 | 840448 | 18 |
Last trade - 16.20pm 27/06/2025 (20 minute delay) ? |
Featured News
BRN (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online